Neurocrine Biosciences Inc. (NBIX) Tops Q4 EPS by 1c; Guides FY11

February 10, 2011 4:23 PM

Neurocrine Biosciences Inc. (NASDAQ: NBIX) reported Q4 EPS of $0.05, $0.01 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found